drugset / Trial / NCT04706286
Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393
RandomizedCrossoverOpen-labelTreatment
Summary
A Clinical Trial to evaluate the Pharmacokinetics and safety of CKD-393 0.5/100/1000 mg under fed condition
Timeline
- Start
- 2021-02-18
- Primary completion
- 2021-03-29
- Completion
- 2021-04-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CKD-393 | Unknown | — | Oral |
| Subject | D150 | Unknown | 1000 mg | Oral |
| Subject | D759 | Unknown | 100 mg | Oral |
| Subject | Lobeglitazone | Small molecule | 0.5 mg | Oral |